InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
3
T+90 hit rate
33%
T+90 mean return
-16.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Schoenberg Mark, Directeur Médical. Director active across 1 company, notably UroGen Pharma Ltd.. In total, 22 reports have been recorded. Split: 1 buy · 3 sells. Total volume traded: €326k. History available since 18 November 2021. The latest transaction was disclosed on 11 August 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
10,000 shares@ US$17.69Ordinary SharesSEC:0001437749-25-026377:0
10,000 sharesOrdinary SharesSEC:0001437749-25-023961:0
10,000 sharesOrdinary SharesSEC:0001437749-25-020045:0
1,334 sharesOrdinary SharesSEC:0001437749-25-002688:0
1,666 sharesOrdinary SharesSEC:0001437749-24-029040:0
10,000 sharesOrdinary SharesSEC:0001437749-24-019900:0
12,000 shares@ US$14.0520.9% of flowOrdinary SharesSEC:0001437749-24-008707:0
1,137 shares@ US$15.782.2% of flowOrdinary SharesSEC:0001437749-24-003153:0
2,000 sharesOrdinary SharesSEC:0001437749-24-003016:0
500 sharesOrdinary SharesSEC:0001437749-23-002336:0
122,677 shares@ US$5.0076.4% of flowOrdinary SharesSEC:0001437749-23-001625:0
500 sharesOrdinary SharesSEC:0001437749-22-025549:0
500 sharesOrdinary SharesSEC:0001437749-22-021337:0
500 sharesOrdinary SharesSEC:0001437749-22-010701:0
500 sharesOrdinary SharesSEC:0001209191-22-006384:0
209 sharesOrdinary SharesSEC:0001209191-22-005416:0
160 shares@ US$13.100.0001% mcap50.0% of flowOrdinary SharesSEC:0001209191-21-065756:0
Ideal exit: 15 Aug 2022 (T+270)
500 sharesOrdinary SharesSEC:0001209191-21-062360:0
208 sharesOrdinary SharesSEC:0001209191-21-061868:0
500 sharesOrdinary SharesSEC:0001209191-21-049477:0
208 sharesOrdinary SharesSEC:0001209191-21-048398:0
500 sharesOrdinary SharesSEC:0001209191-21-029758:0
22 of 22 declarations
About Schoenberg Mark
Mark Schoenberg is an executive at UroGen Pharma Ltd.
